Afluria Global Market Report 2025

Afluria Global Market Report 2025 – By Formulation (Pre-Filled Syringes, Multi-Dose Vials), By Clinical Indication (Influenza Prevention), By Distribution Channel (Hospitals And Clinics, Retail Pharmacies, Government Supplier), By End Users (Pediatric, Adult, Geriatric) – Market Size, Trends, And Global Forecast 2025-2034

Name: Afluria Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Afluria Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Afluria Market Definition

Afluria is an inactivated influenza vaccine designed to protect against infections caused by specific strains of the influenza virus. Approved for individuals aged 6 months and older, it is administered via injection and helps stimulate the immune system to produce antibodies. Annual vaccination is recommended to ensure effective protection against seasonal flu outbreaks.

The main formulations of afluria are pre-filled syringes and multi-dose vials. Pre-filled syringes offer a single-dose option for flu vaccines, ensuring accuracy and ease of use. They are commonly used in outpatient clinics and pharmacies to streamline administration. These syringes reduce contamination risk and support efficient immunization efforts. The clinical indication includes Influenza Prevention and is distributed through hospitals and clinics, retail pharmacies, and government suppliers and utilized by end users such as pediatric, adult, and geriatric.

Afluria Market Segmentation

The afluriamarket covered in this report is segmented –

1) By Formulation: Pre-Filled Syringes, Multi-Dose Vials

2) By Clinical Indication: Influenza Prevention

3) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Government Supplier

4) By End Users: Pediatric, Adult, Geriatric

Afluria Market Size and growth rate 2025 to 2029: Graph

Afluria Market Size 2025 And Growth Rate

The Afluria market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing incidence of influenza, growing geriatric population, rising healthcare expenditure, increasing awareness of vaccine safety, and increase in public health campaigns.

Afluria Market Growth Forecast

The Afluria market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing government support, growing focus on preventative healthcare, rising vaccine hesitancy mitigation efforts, expansion of healthcare systems, and rising income levels in emerging economies. Major trends in the forecast period include telehealth integration for vaccination consultations, investment in cold chain logistics, integration of artificial intelligence in vaccine development, government incentives for vaccination, and collaboration with technology companies.

Book your 30 minutes free consultation with our research experts

Afluria Market Driver: Rising Influenza Prevalence Boosts Afluria Vaccine Market Growth

The growing prevalence of influenza is expected to propel the growth of the afluria market going forward. Influenza, commonly known as the flu, is an infectious respiratory disease caused by influenza viruses that can lead to mild to severe illness, with symptoms including fever, cough, sore throat, body aches, and fatigue. The increasing prevalence of influenza is attributed to factors such as heightened public awareness of the disease, rising incidence rates from virus mutations, and greater demand for vaccinations, especially among vulnerable groups like the elderly. Afluria is used as a vaccine to prevent influenza by stimulating the immune system to produce antibodies against the flu virus. For instance, in November 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, as of October 16, 2024, influenza positivity rose to 2.3% in week 41, up from 2% the previous week, with the highest rates (5.1%) seen in those aged 5 to 14 years. Therefore, the growing prevalence of influenza is driving the growth of the afluria market.

Afluria Market Driver: The Growing Need For Influenza Vaccines Among Older Adults

The growing geriatric population is expected to propel the growth of the afluria market going forward. The geriatric population refers to individuals who are typically aged 65 and older and characterized by unique health needs and challenges associated with aging. The geriatric population is growing due to a combination of declining fertility rates and increasing life expectancy, resulting in a larger proportion of older individuals within the overall population. The geriatric population, which is particularly vulnerable to severe illness and mortality from influenza, necessitates effective vaccination strategies such as afluria to protect older adults and reduce flu-related health complications. For instance, in July 2024, according to a report published by the House of Commons Library, a UK-based government agency, the UK's population is aging, with around 12.7 million people aged 65 and over in 2022, accounting for 19% of the total population, and this number is expected to rise to 22.1 million, or 27% of the population, by 2072. Therefore, the growing geriatric population is driving the growth of the afluria market.

Global Afluria Market Major Players

Major companies operating in the afluria market include CSL Seqirus

Global Afluria Market Trend: Innovative Solutions In The Influenza Vaccine Market Enhanced Growth

The key trend in the afluria market is focusing on developing innovative solutions such as a nano-sized particle-based vaccine to enhance vaccine efficacy, stability, and targeted delivery. A nanoparticle-based vaccine refers to a vaccine that uses tiny particles, often in the nanometer range, to deliver antigens more efficiently and improve immune response. For instance, in March 2024, Cadila Pharmaceuticals Ltd., an India-based pharmaceutical company, launched the Cadiflu Tetra Vaccine, an advanced quadrivalent influenza vaccine aimed at preventing seasonal influenza. This vaccine targets four strains of the influenza virus, specifically subtypes A and B, providing broader protection against flu epidemics. It incorporates key proteins such as hemagglutinin (HA), neuraminidase (NA), and matrix 1 (M1) in a single formulation, contributing to a qualitatively superior vaccine with a better safety profile compared to traditional vaccines.

Regional Outlook For The Global Afluria Market

North America was the largest region in the afluria market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the afluria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the afluria market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Afluria Market?

The afluria market consists of sales of afluria quadrivalent, and afluria trivalent. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Afluria Industry?

The afluria market research report is one of a series of new reports from The Business Research Company that provides afluria market statistics, including the afluria industry's global market size, regional shares, competitors with an afluria market share, detailed afluria market segments, market trends and opportunities, and any further data you may need to thrive in the afluria industry. This afluria market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Afluria Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Formulation: Pre-Filled Syringes, Multi-Dose Vials 2) By Clinical Indication: Influenza Prevention 3) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Government Supplier 4) By End Users: Pediatric, Adult, Geriatric
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	CSL Seqirus
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Afluria Market Characteristics

3. Afluria Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Afluria Market Trends And Strategies

5. Afluria Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Afluria Growth Analysis And Strategic Analysis Framework

6.1. Global Afluria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Afluria Market Growth Rate Analysis

6.4. Global Afluria Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Afluria Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Afluria Total Addressable Market (TAM)

7. Global Afluria Market Pricing Analysis & Forecasts

8. Afluria Market Segmentation

8.1. Global Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pre-Filled Syringes

Multi-Dose Vials

8.2. Global Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Influenza Prevention

8.3. Global Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Retail Pharmacies

Government Supplier

8.4. Global Afluria Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatric

Adult

Geriatric

9. Global Afluria Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Afluria Market Regional And Country Analysis

10.1. Global Afluria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Afluria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Afluria Market

11.1. Asia-Pacific Afluria Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Afluria Market

12.1. China Afluria Market Overview

12.2. China Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Afluria Market

13.1. India Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Afluria Market

14.1. Japan Afluria Market Overview

14.2. Japan Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Afluria Market

15.1. Australia Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Afluria Market

16.1. South Korea Afluria Market Overview

16.2. South Korea Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Afluria Market

17.1. Western Europe Afluria Market Overview

17.2. Western Europe Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Afluria Market

18.1. UK Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Afluria Market

19.1. Germany Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Afluria Market

20.1. France Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Afluria Market

21.1. Eastern Europe Afluria Market Overview

21.2. Eastern Europe Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Afluria Market

22.1. North America Afluria Market Overview

22.2. North America Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Afluria Market

23.1. USA Afluria Market Overview

23.2. USA Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Afluria Market

24.1. Canada Afluria Market Overview

24.2. Canada Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Afluria Market

25.1. South America Afluria Market Overview

25.2. South America Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Afluria Market

26.1. Middle East Afluria Market Overview

26.2. Middle East Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Afluria Market

27.1. Africa Afluria Market Overview

27.2. Africa Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Afluria Market Competitive Landscape And Company Profiles

28.1. Afluria Market Competitive Landscape

28.2. Afluria Market Company Profiles

28.2.1. CSL Seqirus Overview, Products and Services, Strategy and Financial Analysis

29. Global Afluria Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Afluria Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Afluria Market

32. Recent Developments In The Afluria Market

33. Afluria Market High Potential Countries, Segments and Strategies

33.1 Afluria Market In 2029 - Countries Offering Most New Opportunities

33.2 Afluria Market In 2029 - Segments Offering Most New Opportunities

33.3 Afluria Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Afluria Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Afluria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Afluria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: South Korea, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Western Europe, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: UK, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Germany, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: France, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Eastern Europe, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: North America, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: USA, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Canada, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: South America, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Middle East, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Africa, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: CSL Seqirus Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Afluria Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Afluria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Afluria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: South Korea, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Western Europe, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: UK, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Germany, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: France, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Eastern Europe, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: North America, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: USA, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Canada, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: South America, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Middle East, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Africa, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: CSL Seqirus Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the acne drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the digestive health supplements market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the protein purification and isolation market research report 2022 with industry size, share, segments and market growth

Influenza Diagnostic Global Market Report 2025 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests), By Molecular diagnostic tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End User (Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Influenza Vaccines Global Market Report 2025 – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric, Adult), By Distribution Channel (Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Influenza Treatment Global Market Report 2025 – By Product Type (Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Other Products), By Route Of Administration (Oral, Other Routes Of Administration), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Immunoglobulins Global Market Report 2025 – By Product (IGG, IGA, IGM, IGE, IGD. ), By Mode Of Delivery (Intravenous Mode of Delivery, Subcutaneous Mode of Delivery), By Application (Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Treatment Global Market Report 2025 – By Product (Consumables and Assay Kits, Instruments, Services), By Service Type (Consultation and Diagnosis, Therapy and monitoring, Drug development), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases), By Drug Class (Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class), By End User (Clinical Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Intravenous Immunoglobulin Global Market Report 2025 – By Type( IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)), By Distribution Channel( Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels ), By Application( Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications ), By End-User( Hospitals, Clinics, Home Care) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Allergy Immunotherapy Global Market Report 2025 – By Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types), By Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)), By Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Immunohematology Global Market Report 2025 – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)), By Disease (Blood-Related Diseases, HIV, Hepatitis), By Application (Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology), By End User (Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Afluria market?

How will the Afluria market drivers and restraints affect the market dynamics? What forces will shape the Afluria industry going forward?

The Afluria market major growth driver - Rising Influenza Prevalence Boosts Afluria Vaccine Market Growth. For further insights on the Afluria market, request a sample here

What is the forecast market size or the forecast market value of the Afluria market?

The Afluria market size has grown strongly in recent years. The Afluria market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing incidence of influenza, growing geriatric population, rising healthcare expenditure, increasing awareness of vaccine safety, and increase in public health campaigns. The Afluria market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing government support, growing focus on preventative healthcare, rising vaccine hesitancy mitigation efforts, expansion of healthcare systems, and rising income levels in emerging economies. Major trends in the forecast period include telehealth integration for vaccination consultations, investment in cold chain logistics, integration of artificial intelligence in vaccine development, government incentives for vaccination, and collaboration with technology companies. For further insights on the Afluria market, request a sample here

How is the Afluria market segmented?

The afluriamarket covered in this report is segmented –
1) By Formulation: Pre-Filled Syringes; Multi-Dose Vials
2) By Clinical Indication: Influenza Prevention
3) By Distribution Channel: Hospitals And Clinics; Retail Pharmacies; Government Supplier
4) By End Users: Pediatric; Adult; Geriatric For further insights on the Afluria market, request a sample here

Which region has the largest share of the Afluria market? What are the other regions covered in the report?

Who are the major players in the Afluria market?

Major companies operating in the afluria market include CSL Seqirus . For further insights on the Afluria market, request a sample here.

What are the key trends in the Afluria market?

Major trends in the Afluria market include Innovative Solutions In The Influenza Vaccine Market Enhanced Growth. For further insights on the Afluria market, request a sample here.

What are the major opportunities in the Afluria market? What are the strategies for the Afluria market?

For detailed insights on the major opportunities and strategies in the Afluria market, request a sample here.

How does the Afluria market relate to the overall economy and other similar markets?

For detailed insights on Afluria's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Afluria industry?

For detailed insights on the mergers and acquisitions in the Afluria industry, request a sample here.

What are the key dynamics influencing the Afluria market growth? SWOT analysis of the Afluria market.

For detailed insights on the key dynamics influencing the Afluria market growth and SWOT analysis of the Afluria industry, request a sample here.